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QUANTITATIVE ASSAY OF BINARY AND TERNARY CARDIOVASCULAR MIXTURES 
USING ABSORPTION SUBTRACTION SPECTROPHOTOMETRIC METHOD 
Abstract 
Objective: Development and validation of specific spectrophotometric analytical method for the 
simultaneous determination of co-administered cardiovascular mixtures consisting of Aspirine (ASP) and 
Prasugrel (PRA) binary mixture and Ticagrelor (TICA), Irbesartan (IRB) and Hydrochlorothazide (HCT) 
ternary mixture. 
Methods: The proposed spectrophotometric method was based on Absorbance Subtraction, where, when 
a mixture of two drugs X and Y having overlapped spectra, intersecting at isoabsorptive point and Y 
spectrum is extended more than X, while X doesn’t show any absorbance (A2) at another wavelength (λ2), 
X and Y could be determined in the mixture by simple mathematical manipulation 
Results: This method obeyed Beer’s law in the concentration range of 5-50 μg/ml for ASP, 5-25 μg/ml for 
PRAS, 10-30 μg/ml for TICA, 0.5-2 μg/ml for IRB, 4-10 μg/ml for HCT. The suggested method was applied 
on laboratory prepared mixtures and was successfully applied in quality control analysis of combined 
pharmaceutical dosage forms. The developed spectrophotometric method was validated statistically and 
recovery studies were carried out, where excellent percentage recoveries were obtained. The developed 
spectrophotometric method was also compared to reference HPLC methods. 
Conclusion: The developed spectrophotometric method based on absorption subtraction is an easy, simple 
and time saving method, that was able to determine the active ingredients in the binary and ternary 
pharmaceutical formulation without any interference from then excipients. 
Keywords 
Binary, ternary, cardiovascular mixtures, absorption subtraction method, multicomponent Formulation, 
Validation 





Cardiovascular drugs often work best in combination, since multiple conditions are behind 
most cardiovascular problems. Moreover, multicomponent formulations are gaining interest due 
to greater patient acceptability, increased potency, multiple action, fewer side effects, and quicker 
relief. Antiplatelet therapy is the cornerstone of treatment for patients with acute coronary 
syndrome as it prevents ischemic events in patients undergoing Percutaneous coronary 
intervention (Wiviott et al., 2007). Cardiovascular diseases accompanied with high blood pressure 
are the largest risk factor for premature death. Some patients with hypertension require two or 
more antihypertensive and anti-platelet drugs with complementary mechanisms of action to 
control their cardiovascular condition. The angiotensin II type 1-receptor antagonist Irbesatran 
(IRB), the diuretic Hydrochlorothiazide (HCT) and the anti-platelet Ticargrelor (TICA) have 
recognized clinical efficacy and protective effect on the cardiovascular system. Therefore, the 
combination of the three drugs been found to be more effective than either drug alone in the 
treatment of cardiovascular diseases not adequately controlled by monotherapy. As well, PRA in 
combination with aspirin showed to have more potent antiplatelet effects and faster onset of 
activity (Angiolillo et al., 2008).  IRB (IRB), chemically described as 2-butyl-3-[[2′-(1H-tetrazol-
5-yl)[1,1′-biphenyl]-4-yl]-methyl1-3-diazaspiro-[4,4]-non-1-en-4-one, (Fig. 1) is an angiotensin 
II blocker, which acts mainly by selective blockade of AT1 receptors and reduces the effects of 
angiotensin II. IRB may be used alone or in combination with other antihypertensive or diuretic 
agents (O’Neil et al., 2001).  Hydrochlorothiazide (HCT), chemically described as 6-chloro-3, 4-
dihydro-2H-1, 2, 4-benzothiadiazine-7-sulphonamide-1, 1-dioxide, (Fig. 2), is a thiazide diuretic. 
It increases sodium and chloride excretion in distal convoluted tubule. Because of their synergistic 
anti-hypertensive action, IRB and Hydrochlorothiazide are available in the market as a combined 
dosage form (Bank, 2013).  
TICA(TICA),  chemically described as (1S,2S,3R,5S)-3-[7-{[(1R,2S)-2-(3,4-
difluorophenyl)cyclopropyl]amino}-5-(propylthio)-3H-[1,2,3]-tria zolo [4,5-d]pyrimidin-3-yl]-
5-(2-hydroxyethoxycyclo pentane-1,2-diol2, (Fig. 3), is an orally active antiplatelet agent 
indicated to reduce the rate of thrombotic cardiovascular events in patients with acute coronary 
syndrome. TICA and its major metabolite reversibly interact with the platelet P2Y12 ADP-
receptor to prevent signal transduction and platelet activation, which inhibits platelet aggregation 
and thrombus formation in atherosclerotic disease.  Aspirin (ASP), chemically described as 2-
(Acetyloxy) benzoic acid (Fig. 4) is a nonsteroidal anti-inflammatory drug and platelet 
aggregation inhibitor. Acetylsalicylic acid binds to acetylates serine residues in cyclooxygenases, 
resulting in decreased synthesis of prostaglandin, platelet aggregation, and inflammation 
(Vemugunta et al., 2012) PRA (PRA), chemically described as [5-[2-cyclopropyl-1-(2-
fluorophenyl)-2-oxoethyl]-6, 7-dihydro-4H-thieno [3, 2-c] pyridin-2-yl] acetate hydrochloride 
(Fig. 5) is a platelet activation and aggregation inhibitor. PRA is a prodrug that requires enzymatic 
transformation in the liver to its active metabolite. Ii irreversibly binds to ADP receptors on 












   
  Fig.1: Irbesartan                              Fig.2: Hydrochlorobiazide                                  Fig.3: Ticagrelor 
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                                 Fig.4: Aspirin                                        Fig.5: Prasugrel  
 
Several analytical methods have been reported for the determination of IRB in pure and 
pharmaceutical dosage forms using spectrophotometry. Extractive and non-extractive (El Sutohy 
et al., 2013) spectrophotometry spectrofluorometry. In presence of hydrochlorothiazide, IRB has 
been determined by UV-Spectroscopy. Hydrochlorothiazide has been determined individually by 
spectrophotometry. In combination with many other drugs, Hydrochlorothiazide has been 
determined by spectrophotometric Chemometric analysis (Farouk et al., 2011; Patel et al., 2011). 
Sequential Spectrophotometry (Sridharan et al., 2010). Hydrochlorothiazide was assayed in 
combination with many other drugs using H-point standard addition method (Lakshmi et al., 
2011; Sivasubramanian et al., 2015). TICA has been assayed by spectrophotometry (Pendaya et 
al., 2016). PRA has been determined individually by extractive spectrophotometry (22), 
colorimetric method(Harshini et al., 2011), HPLC (Mullangi et al., 2012; Prabahar et al., 2011) 
and HPTLC (Damle et al., 2017). In combination with ASP, PRA has been determined by HPLC 
(Patel et al., 2013; Martos et al., 2000), spectrophotometry (Chhonker et al., 2016),  
spectrofluorimetry (Porwal et al., 2015). ASP has been determined in presence of Clopidogrel in 
human plasma (Lotfy, 2014). ASP has been determined in presence of many other drugs  by LC 
and  HPLC. In this work, green analytical spectrophotometric method has been developed for the 
analysis of PRA and ASP binary combination and IRB, TICA and HCT ternary combination in 
synthetic mixtures and laboratory made tablets. The suggested spectrophotometric method is able 
to resolve the overlapped spectra by simple manipulation step, the absorbance values 
corresponding to the studied drugs could be easily obtained. The spectrophotometric method was 





2.1 Theoretical Background 
The Absorbance Subtraction method is based on the same principle as the absorption 
factor method (Lotfy, 2014) and it depends on that, if you have a mixture of two drugs X and 
Y having overlapped spectra, intersecting at isoabsorptive point and Y is extended more than 
X, while X doesn’t show any absorbance (A2) at another wavelength (λ2), X and Y could be 
determined in the mixture by simple mathematical manipulation. In the absorbance 
subtraction method (AS) the isoabsorptive point (λiso) could be used for the separate 
quantitative determination of each X & Y in their mixture (X+Y). The determination can be 
done using mathematically calculated factor of one of these components. So, the 
Concentration of each component could be obtained via the isoabsorptive point regression 
equation without any need for a complementary method. The absorbance values 
corresponding to X and Y at λiso were calculated by using absorbance factor {Aiso / A2} 
which is a constant for pure Y representing the average of the ratio between the absorbance 
values of different concentrations of pure Y at λiso divide be the absorbance values of pure Y 
at λ2. 
Absorbance of Y in the mixture at λiso = Ay λiso/ Ay λ2 × A(x+y) λ2.  
Absorbance of X in the mixture at λiso = A(x+y) λiso – (Ay λiso / Ay λ2) × A(x+y) λ2. 
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Where; Ay λiso and Ay λ2 is the absorbance value of pure Y at λiso and  λ2; Ay λiso/ 
Ay λ2 is called the absorbance factor and abs λiso (X + Y) and abs λ2(X + Y) are the 
absorbance of the mixture at these wavelengths (λiso, λ2). 
The concentration of each of X or Y is separately calculated using the isoabsorptive 
point regression equation that is obtained by plotting the absorbance values or the ratio signals 
of X or Y at isoabsorptive point (λiso) against their corresponding concentrations. 
2.2 MATERIALS AND METHODS  
Apparatus 
The spectrophotometric measurements were carried out on a Jasco V-530 double beam 
UV-Vis Spectrophotometer connected to a computer loaded with Jasco UVPC software and 
HP Deskjet 5652 printer. The spectrophotometer is supported with Jasco Spectra Manager 





Aspirin and PRA (supplied by SIGMA-ALDRICH) were used as working standards. 
TICA(supplied by Omnipharma, Astrazenica, Lebanon), IRB and Hydrochlorothiazide 
(supplied by Algorithm, Lebanon). Methanol (supplied by SIGMA-ALDRICH 
CHROMASOLV® FOR HPLC>99.9%) was used as solvent. 
 
Standard stock solutions 
The standard stock solutions were separately diluted with methanol to prepare working 
standards having the concentrations of 100 µg.mL-1 TICA, 10 µg.mL-1 IRB, 40µg.mL-1 
HCT, 100 µg.mL-1 ASP and 100 µg.mL-1 PRA. 
Working standard solutions 
Standard solutions of TICA (1000 µg.mL-1), IRB (100 µg.mL-1), HCT(400 µg.mL-1), 




Into series of 10-mL measured flasks, volumes from the above prepared working 
standard solutions of ASP, PRA TICA, IRB or HCT, were separately transferred and diluted 
with methanol to give the final concentrations stated in Table 1.  
 
Synthetic mixtures 
Six validation synthetic mixtures from the binary and ternary mixtures were prepared 
by mixing appropriate volumes of the working standard solutions of ASP and PRA or TICA, 
IRB and HCT and diluting to volume with methanol. The combination of ASP and PRA or 
TICA, IRB and HCT are illustrated in Table 2. 
The absorbance values for each solution of the calibration graph and the prepared 
synthetic mixtures were recorded at 1-nm intervals in the wavelength range 200-300 nm 
For ASP and PRA determination, the A spectra of the standard solutions and their 
mixtures were recorded at 223 and 256 nm. 
For TICA and HCT determination, the ratio spectra of the standard solutions and their 
mixtures were recorded at 214 and 240 nm, where the ratio spectra are obtained by dividing 
the absorption spectra of the three analyte and their mixtures by the spectra of 0.5 µg.mL-1 
IRB standard solution).  
For IRB and HCT determination, the ratio spectra of the standard solutions and their 
mixtures were recorded at 229 and 240 nm, where the ratio spectra are obtained by dividing 
the absorption spectra of the three analyte and their mixtures by the spectra of 12.5 µg.mL-1 
TICA standard solution). 
Regression equations of the signals obtained versus the standard concentration of 
analyte are derived to quantify each of the studied drugs in their binary or ternary mixtures. 
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Laboratory made tablets 
Accurately two sets of ten laboratory made tablets; the first set containing 100 mg ASP 
and 10 mg PRA per tablet, and the second set containing 90 mg TICA, 15 mg IRB and 50 mg 
HCT per tablet (in addition to lactose, starch, talc and magnesium stearate as tablet fillers) 
were weighed and powdered. Accurate weight (equivalent to 10 mg ASP and 1 mg PRA) or 
(equivalent to 9 mg TICA, 1.5 mg IRB and 5 mg HCT) of the finely powdered tablets were 
transferred into two separate 100-mL calibrated flasks, 50 mL methanol were added and the 
flasks were shaken for 15 min, filtered and completed to volume with methanol. 1-mL of each 
of the prepared solutions, was transferred into two separate 10-mL calibrated flask and diluted 
to volume with methanol to prepare tablet solutions containing 5 μg.mL-1 PRA and 50 μg.mL-
1 ASP or 9 μg.mL-1 TICA, 1.5 μg.mL-1 IRB and 5 μg.mL-1 HCT. The absorption spectra of 




Quantitative analysis often involves the spectrophotometric resolution of mixtures of two 
or more components with partly overlapping spectra. The extensive overlapping between the 
absorption spectra of ASP and PRA and TICA, IRB and HCT in Fig. 6 and Fig. 7 respectively is 
sufficiently clear, making the resolution using the direct UV-Vis spectrophotometry more difficult. 
Thus, the need for the development of mathematical treatment of the data. Absorption subtraction 
method is one of the easily applied method in which minimal treatment of the data is done. This 
method could be used if there is existence of an isoabsorptive point for the drugs in mixture and 
extension of the spectra of the other component.  
 
 























215 225 235 245 255 265 275 285 295
A
Wavelength(nm)ASP PRA Their mixture
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4. DISCUSSION 
Fig. 6 shows that the A spectra of ASP and PRA exhibit an isoabsorptive point at 223 nm 
and it is also clear that the A spectrum of ASP is more extended in the spectral region between 
245-260 nm, Thus the AS method could be applied for the determination of ASP and PRA in 
presence of each other. By the analysis of the recorded A values for ASP, PRA and their mixture 
at 223 nm and 256 nm, the ratio signals of ASP and PRA could be separately calculated from the 
following equations: 
 
Absorbance of PRA in the mixture at λ223 = APRAS λ223/ APRAS λ256 × A(ASP+PRAS) λ256. 
  
Absorbance of ASP in the mixture at λ223 = A(ASP+PRA) λ223 – (APRA λ223 / APRA λ256)× 
A(ASP+PRA) λ256, 
 
Where, the APRA λ223 / APRA λ256 is the absorbance factor of pure PRA at 223 and 256 nm. 
 
To be able to quantify TICA or HCT, in their ternary mixture, AS method, has been 
developed on the ratio spectra (Fig. 8); where the effect of IRB has been eliminated by dividing 
the zero absorption spectrum of the mixture by the zero order spectrum of a standard IRB solution. 
Upon this division, constant spectrum equivalent to the contribution of IRB in the mixture is 
generated (AIRB/ A IRB0).  Subtracting the value of this constant from the ratio spectrum, will 
give ratio signals equivalent to TICA and IRB only. On the obtained ratio signals, SA method has 
been applied to determine the concentration TICA and HCT. 
 
Fig. 8 shows that the ratio spectra of  TICA and HCT, exhibit an isoabsorptive point at 214 
nm and it is also clear that the ratio spectrum of HCT is more extended in the spectral region 
between 235-245 nm, Thus the AS method could be applied for the determination of TICA and 
HCT in presence of each other. By the analysis of the recorded ratio signals for TICA, HCT and 
their mixture at 214 nm and 240 nm, the ratio signals of TICA and HCT could be separately 
calculated from the following equations: 
 
Ratio signal of TICA in the mixture at λ214 = RTICA λ214/ RPTICA λ240 × R(TICA+HCT) 
λ240.  
 
Ratio signal of HCT in the mixture at λ214= R(TICA+HCT) λ214 – (RTICAλ214 / RTICA λ240) 
× R(TICA+HCT) λ240, 
 













200 210 220 230 240 250 260 270
Ratio 
Wavelength(nm)HCT/IRB TICA/IRB Their mixture
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To be able to quantify IRB in its ternary mixture, AS method, has been developed on the 
ratio spectra (Fig. 9); where the effect of TICA has been removed by dividing the zero absorption 
spectrum of the mixture by the zero order spectrum of a standard TICA solution. Upon this 
division, constant spectrum equivalent to the contribution of TICA in the mixture is generated 
(ATICA/ A TICA0).  Subtracting the value of this constant from the ratio spectrum, will give ratio 
signals equivalent to TICA and IRB only. On the obtained ratio signals, SA method has been 
applied to determine the concentration IRB and HCT. 
 
Fig. 9 shows that the ratio spectra of  IRB and HCT, exhibit an isoabsorptive point at 229 
nm and it is also clear that the ratio spectrum of HCT is more extended in the spectral region 
between 235-245 nm, Thus the AS method could be applied for the determination of IRB and HCT 
in presence of each other. By the analysis of the recorded ratio signals for IRB, HCT and their 
mixture at 229 nm and 240 nm, the ratio signals of IRB and HCT could be separately calculated 
from the following equations: 
 
Ratio signal of IRB in the mixture at λ229 = RIRB λ229/ RIRB λ240 × R (IRB+HCT) λ240.  
Ratio signal of HCT in the mixture at λ229= R (IRB+HCT) λ229 – (RTICAλ229 / RTICA λ240) 
× R(IRB+HCT) λ240, 





Fig.9: The ratio spectra of 0.5 µg/mL IRB  and 4 µg/mL HCT, divided by the spectra of 12.5 µg/mL TICA 
 
 
Method validation and statistical analysis 
The proposed method was validated according to ICH guidelines. The validation parameters 
included: linearity, limits of detection and quantification, accuracy, precision and specificity. The 
applied specrophotometric analytical method was able to quantify the studied drugs in their double 
and ternary mixtures. 
 
Linearity and concentration ranges 
Under the described experimental conditions, the graphs obtained by plotting the signals of 
the proposed method versus concentration for ASP, PRA, TICA, IRB and HCT gave linear 
relationships over the concentration ranges stated in Table 1. Linearity data and statistical 
parameters for the proposed method were calculated, including linear regression equation 
parameters (intercepts, slopes, correlation coefficients, standard deviation of intercept and 
standard deviation of the slope (Table 1). Regression analysis confirmed good linearity as shown 
from correlation coefficient value (r> 0.999). The high F-value proved that the linear correlation 
between calculated signals (spectrophotometric method) and concentrations in significant to a high 
level of confidence. The high values of the correlation coefficient (r) with negligible intercepts 
indicate the good linearity of the calibration graphs. Standard deviation of residuals (Sy/x), of 
intercept (Sa) and of slope (Sb) are presented for each drug. (Sy/x) is a measure of the extent of 
deviation of the found (measured) y-values from the calculated ones. Also, the small degree of 
scatter of the experimental data point around the line of regressions was confirmed by the small 








200 210 220 230 240 250 260 270 280 290
Ratio 
Wavelength(nm)IRB/TICA HCT/TICA Their mixture
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Limit of detection (LOD) and limit of qualification (LOQ) 
Limits of detection (LOD) and quantification (LOQ) were calculated according to the ICH 
guidelines (33). LOD was defined as 10 Sa/b, where Sa is the standard deviation of the intercept 
and b is the slope of the calibration curve. The sensitivity of the proposed methods can be 
confirmed by the low LOD and LOQ values obtained in Table 1. The variance test for the 
regression lines revealed that, for equal degrees of freedom, the increase in the variance ratio (F-
values) means an increase in the mean squares due to regression and a decrease in the mean squares 
due to residuals, (the less is the scatter of experimental points around the regression line). 
Consequently, regression lines with high F-values (low significance F) are much better than those 
with lower ones. Good regression lines show high values for both r and F statistical parameters 
(Armitage et al., 2008).  
 
Accuracy 
The applicability of the developed method was tested by the analysis of ASP-PRA and 
TICA-IRB-HCT in several synthetic mixtures of different proportions. Each solution was 
measured in triplicate, and the recoveries were calculated. Good accuracy, expressed as percentage 
relative error (Er %) were obtained. The results, summarized in Table 2 show that the calculated 





Intra-day precision was determined by analyzing the prepared mixtures for five times in the 
same day. Inter-day precision was determined by analyzing the prepared mixtures individually for 
three successive days.  High precision expressed as % RSD were obtained. The results are 
summarised in Table 3 where the values of % RSD did not exceeded the accepted limits which 
demonstrate the precision of the method. 
 
Laboratory made mixtures 
 
Table 4 presents a statistical comparison between the proposed method and a reference RP-
HPLC method for the assay of ASP and PRA binary combination, TICA, IRB and HCT ternary 
combination by using the student’s t-test and the variance ratio F-test. Since the calculated t- and 
F- values for each drug did not exceed the theoretical ones, this indicated that there was no 
significant difference between the applied methods for determination of the two drugs in 
commercial tablets. 
 
Table 1:  Assay parameters for the determination of ASP, PRA, TICA, IRB or HCT in their binary or 
ternary mixtures using the Absorption subtraction method 
 
 ASP PRA PRA TICA TICA IRB IRB HCT 
Conc. Range 
(µg.mL-1) 
5-50 5-25 5-25 10-30 10-30 0.5-3 0.5-3 4-10 
λ  (nm) 223 223 256 229 240 229 240 229 
r 0.9995 0.9986 0.9998 0.999 0.9990 0.9995 0.9983 0.9991 
S y/x 0.16 x10
-2 0.39 x10-3 1.56 x10-5 0.40 x10-3 0.19 x10-3 1.15 x10-3 1.81 x10-3 0.15 x10-3 
F 3263 1120 11654 1642 1564 3110 892 1192 
Significance F 1.18 x10-5 5.86 x10-5 1.75  x10-6 3.30 x10-5 3.55 x10-5 1.27 x10-5 8.23 x10-5 0.83 x10-3 
a (intercept) -0.11 x10-1 0.21 x10-1 0.23 x10-2 -0.10 x10-1 -0.15 x10-1 -0.18 x10-1 0.28 x10-1 0.15 x10-1 
b (slope) 0.42 x10-1 0.24 x10-1 0.15 x10-1 0.29 x10-1 0.20 x10-1 0.56 0.38 0.66 x10-1 
Sa 0.24 x10
-1 0.12 x10-1 0.23 x10-2 0.15 x10-1 0.11 x10-1 0.18 x10-1 0.23 x10-1 0.14 x10-1 
Sb 0.74 x10
-3 0.72 x10-3 0.14 x10-3 0.73 x10-3 0.51 x10-3 0.11  x10-1 0.12 x10-1 0.19  x10-2 
LOD (µg/mL) 1.74 1.48 0.46 1.57 1.60 0.97 x10-1 0.18 0.63 
LOQ (µg/mL) 5.80 4.90 1.50 5.20 5.36 0.32 0.61 2.12 
a/Sa -0.43 1.71 0.96 -0.64 -1.37 -0.99 1.24 1.05 
(Sb)2 5.52 x10
-7 5.24 x10-7 2.08 x10-8 5.33 x10-7 2.63 x10-7 0.10 x10-3 0.16 x10-3 3.75 x10-6 
Sb % 0.74 x10
-1 0.72 x10-1 0.14 x10-1 0.73 x10-1 0.51 x10-1 1.02 1.27 0.19 
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Table 2: Assay results for the determination of ASP-PRA and TICA-IRB-HCT and in 
synthetic mixtures using the Absorbance subtraction method. 
 
























































                   a Mean ± SD for the three determinations 
                  b % Relative standard deviation 
                  c % Relative error 
 
 
Table 3: Intra-day and inter-day precision for the simultaneous determination of ASP and PRA, TICA, 
IRB and HCT, in laboratory-made mixtures using the proposed RP-HPLC methods 
a Mean ± SD for the five determinations 
b% Relative standard deviation 















Mean Recovery ± SDa 
RSD%b 
Er%c 





99.44 ± 1.38 
1.38 
-0.51 
99.01 ± 0.98 
0.99 
-0.99 











Mean Recovery ± SDa 
RSD%b 
Er%c 
 TICA IRB HCT TICA IRB HCT 
9 : 1.5 : 5 
99.82 ± 0.83 
0.83 
-0.18 
99.32 ± 1.07 
1.07 
-0.68 
101.21 ± 0.86 
0.85 
1.21 
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Table 4: Assay results for ASP-PRA and TICA-IRB-HCT in their laboratory made tablets using the 
proposed Absorption subtraction method 
 
   
a Mean ± SD for the five determinations 
b% Relative standard deviation 
c% Relative error 
**Theoretical values of t- and F- at P = 0.05 are 2.13 and 6.93, respectively 
                             
5. CONCLUSION 
For analytical purposes, it is always important to establish methods capable of analysing co 
administered drugs in short period of time with acceptable accuracy and precision. The developed 
spectrophotometric method is simple, inexpensive, require easy treatment of the samples and is 
based on simple mathematical and statistical background.  The Absorption subtraction method 
demonstrated its ability to resolve the binary and ternary co-administered mixtures and 
individually quantify each of their components. The Absorption subtraction method could be well 
adopted since it gave satisfactory results in the analysis of synthetic mixtures, and proved to be 
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RSD %b 
Er %c 












































TICA : IRB : HCT 
9 : 1.5 : 5 
µg/mL 
Mean Recovery ± SDa 
RSD %b 
Er %c 






























































        3.25 
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